Following the increase in the availability of hemp flowers rich in CBD in many Italian shops, a study was conducted to understand the impact on sales of other products. The findings have just been published. This article takes a closer look at the subject.
CBD flower sales in Italy: what impact on the market?
CBD is now booming in many European countries, particularly in Italy, where availability has increased dramatically in recent years. To understand the impact of Italian consumers’ use of High Society CBD flowers, researchers conducted a study, which you can read by clicking here.
The study was published in the highly regarded Journal of Health Economics in October 2020. It compiled and analysed monthly medicine sales over a full two-year period, from 2016 to 2018, using data from an Italian association of pharmacy managers.
What impact could the unintended liberalisation of a CBD-rich hemp product have had?
This study revealed some very interesting information about changes in medicine consumption following the introduction and availability of CBD-rich hemp flowers containing no more than 0.6% THC:
- Sales of anxiolytics fell by 11.5% over the period concerned
- Sales of sedatives fell by 10% over the period concerned
- Sales of antipsychotics fell by 4.8% over the period concerned
“We find that reductions in the number of medicines dispensed begin in the second month after local retailers start selling CBD-rich hemp flowers, and become more pronounced from the third month. We document a significant substitution effect between light cannabis and anxiolytics, sedatives, opioids, antidepressants and antipsychotics.”
CBD-rich hemp flowers more readily available
Since 2016, shops selling CBD-rich hemp flowers have sprung up across Italy, eventually reaching every province. The figure below shows the growth in the number of shops selling CBD flowers in Italy since 2017:

“Widespread access to the new product, which was promoted as relaxing, led some patients to abandon conventional medicine in search of relief,” the authors concluded.
They note, however, that this has unfortunately led some patients to self-medicate and stop their medical treatment. This is one of the risks to avoid: CBD use is something to discuss with your doctor.